摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[6-fluoro-1-(4-toluenesulfonyl)indol-3-yl]carboxaldehyde | 863407-41-4

中文名称
——
中文别名
——
英文名称
[6-fluoro-1-(4-toluenesulfonyl)indol-3-yl]carboxaldehyde
英文别名
6-Fluoro-1-(4-methylphenyl)sulfonylindole-3-carbaldehyde
[6-fluoro-1-(4-toluenesulfonyl)indol-3-yl]carboxaldehyde化学式
CAS
863407-41-4
化学式
C16H12FNO3S
mdl
——
分子量
317.341
InChiKey
FTDFAAGCUGVNPN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    519.9±60.0 °C(Predicted)
  • 密度:
    1.35±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    64.5
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [6-fluoro-1-(4-toluenesulfonyl)indol-3-yl]carboxaldehyde 在 lithium aluminium tetrahydride 、 palladium diacetate 、 三乙酰氧基硼氢化钠 、 sodium hydride 作用下, 以 四氢呋喃乙醚乙醇二氯甲烷 为溶剂, 生成 {(1R,2R)-2-[6-Fluoro-1-(toluene-4-sulfonyl)-1H-indol-3-yl]-cyclopropylmethyl}-dimethyl-amine
    参考文献:
    名称:
    Conformationally Restricted Homotryptamines. 2. Indole Cyclopropylmethylamines as Selective Serotonin Reuptake Inhibitors
    摘要:
    A series of indole cyclopropylmethylamines were found to be potent serotonin reuptake inhibitors. Nitrile substituents at the 5 and 7 positions of the indole ring gave high affinity for hSERT, and the preferred cyclopropane stereochemistry was determined to be (1S,2S)-trans. The cis-cyclopropanes had 20- to 30-fold less affinity than the trans, and the preferred cis stereochemistry was (1R,2S)-cis. Substitution of the indole N-1 position with methyl or ethyl groups gave a 10- to 30-fold decrease in affinity for hSERT, suggesting either a hydrogen-bonding interaction or limited steric tolerance in the region of the indole nitrogen. Compound (+)-12a demonstrated potent hSERT binding (K-i = 0.18 nM) in vitro and was more than 1000-fold less potent at hDAT, hNET, 5-HT1A, and 5-HT6. In vivo, (+)-12a produced robust, dose-dependent increases in extracellular serotonin in rat frontal cortex typical of a selective serotonin reuptake inhibitor. The maximal response produced by (+)-12a was similar to that of fluoxetine but at an approximately 10-fold lower dose.
    DOI:
    10.1021/jm0503291
  • 作为产物:
    描述:
    6-氟吲哚 在 sodium hydride 、 三氯氧磷 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 11.83h, 生成 [6-fluoro-1-(4-toluenesulfonyl)indol-3-yl]carboxaldehyde
    参考文献:
    名称:
    通过瞬态导向基团策略钯催化羧酸对吲哚进行区域选择性 C4-H 酰氧基化
    摘要:
    开发一种有效的 C4 氧基取代吲哚合成方法是一项有吸引力但具有挑战性的任务。在此,我们报告了一种用于吲哚直接 C4-H 酰氧基化的通用钯催化 TDG 方法。该协议具有原子和步骤经济性、优异的区域选择性和良好的官能团耐受性。此外,该反应可以适应一系列羧酸,包括苯甲酸、苯乙酸和脂肪酸。
    DOI:
    10.1021/acs.orglett.3c03568
点击查看最新优质反应信息

文献信息

  • A highly efficient method for the construction of cyclopropane-containing dihydroindole derivatives from indolemethylenecyclopropanes with DIAD and DEAD
    作者:Mintao Chen、Wenqing Zang、Yin Wei、Min Shi
    DOI:10.1039/c9ob02520k
    日期:——
    A highly efficient method for the construction of cyclopropane-containing dihydroindole derivatives from indolemethylenecyclopropanes with DIAD and DEAD has been disclosed. The transformation could occur under catalyst-free conditions at ambient temperature to afford dihyroindole derivatives in good yields. It has been proved that the strained moiety of methylenecyclopropane in the substrate of in
    已经公开了一种利用DIADDEAD由吲哚亚甲基环丙烷构造含环丙烷的二氢吲哚生物的高效方法。该转化可以在室温下在无催化剂的条件下发生,以良好的产率提供二氢吲哚生物。已经证明吲哚亚甲基环丙烷底物中亚甲基环丙烷的应变部分是关键的,并且DFT计算显示该反应通过两步途径进行。
  • Rhodium(I)‐Catalyzed Benzannulation of Heteroaryl Propargylic Esters: Synthesis of Indoles and Related Heterocycles
    作者:Xiaoxun Li、Haibo Xie、Xiaoning Fu、Ji‐tian Liu、Hao‐yuan Wang、Bao‐min Xi、Peng Liu、Xiufang Xu、Weiping Tang
    DOI:10.1002/chem.201602088
    日期:2016.7.18
    A de novo synthesis of a benzene ring allows for the preparation of a diverse range of heterocycles including indoles, benzofurans, benzothiophenes, carbazoles, and dibenzofurans from simple heteroaryl propargylic esters using a unified carbonylative benzannulation strategy. Multiple substituents can be easily introduced to the C4–C7 positions of indoles and related heterocycles.
    苯环的从头合成可以使用统一的羰基苯环化策略,从简单的杂芳基炔丙酸酯制备各种范围的杂环,包括吲哚苯并呋喃苯并噻吩咔唑二苯并呋喃。可以将多个取代基轻松引入吲哚和相关杂环的C4-C7位。
  • [EN] ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS<br/>[FR] DÉRIVÉS DE CARBOXAMIDE SUBSTITUÉS PAR ARYLE COMME INHIBITEURS DES CANAUX CALCIQUES OU SODIQUES
    申请人:RAQUALIA PHARMA INC
    公开号:WO2010137351A1
    公开(公告)日:2010-12-02
    The present invention relates to aryl substituted carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof, which have blocking activities of T-type calcium channels or voltage gated sodium channels as the tetrodotoxin-sensitive (TTX-S)blockers such as NaV1.3 and NaV1.7, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels or voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels or voltage gated sodium channels are involved.
    本发明涉及式(I)或其药物可接受的盐的芳基取代羧酰胺衍生物,其具有T型通道或电压门控通道的阻断活性,如NaV1.3和NaV1.7等Tetrodotoxin敏感(TTX-S)阻断剂,适用于治疗或预防涉及T型通道或电压门控通道的疾病和紊乱。本发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及T型通道或电压门控通道的疾病中使用这些化合物和组合物的用途。
  • Pd(II)-Catalyzed Transient Directing Group-Assisted Regioselective Diverse C4–H Functionalizations of Indoles
    作者:Anurag Singh、Arnab Dey、Kuntal Pal、Om Prakash Dash、Chandra M. R. Volla
    DOI:10.1021/acs.orglett.2c00320
    日期:2022.3.18
    (TDG)-assisted methodology for realizing C4 chlorination/bromination of indoles employing glycine as the TDG and NFSI as a bystanding oxidant. The use of inexpensive and commercially available CuX2 as the halide source is the key highlight of this protocol. Furthermore, the TDG methodology was also extended to accessing C4 acetoxylated indoles employing acetic acid as the acetate source and 1-fluoro-2,4
    开发一种合理的策略来实现吲哚的位点选择性 C4-H 卤化是一项有吸引力但具有挑战性的任务。在此,我们公开了一种 Pd(II) 催化的瞬态导向基团 (TDG) 辅助方法,用于实现吲哚的 C4 化/化,采用甘酸作为 TDG,NFSI 作为备用氧化剂。使用廉价且市售的 CuX 2作为卤化物源是该协议的主要亮点。此外,TDG 方法还扩展到使用乙酸作为乙酸盐源和 1-fluoro-2,4,6-trimethylpyridinium triflate 作为氧化剂的 C4 乙酰氧基化吲哚
  • ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS
    申请人:Inoue Tadashi
    公开号:US20120101105A1
    公开(公告)日:2012-04-26
    The present invention relates to aryl substituted carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof, which have blocking activities of T-type calcium channels or voltage gated sodium channels as the tetrodotoxin-sensitive (TTX-S) blockers such as Na v1.3 and Na v1.7 , and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels or voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels or voltage gated sodium channels are involved.
    本发明涉及公式(I)或其药学上可接受的盐的芳基取代羧酰胺衍生物,其具有T型通道或电压门控通道的阻滞活性,如Nav1.3和Nav1.7等Tetrodotoxin敏感(TTX-S)阻滞剂,并且在涉及T型通道或电压门控通道的疾病或疾病的治疗或预防中有用。本发明还涉及包含这些化合物的制药组合物以及在涉及T型通道或电压门控通道的疾病或疾病的预防或治疗中使用这些化合物和组合物的用途。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫